The mechanisms for Mab susceptibility in CF patients are exacerbated by hyper-inflammation, the presence of a thickened mucus membrane, and ciliary dysfunction that primarily result from mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene [39,40]. Here, CFTR is linked to cystic fibrosis.